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The role of microglial motility in the context of adult neurodegeneration is poorly understood. In the
present work, we investigated the microanatomical details of microglia-neuron interactions in an
experimental mouse model of Parkinson’s disease following the intraperitoneal injection of MPTP. The
specific intoxication of dopaminergic neurons induces the cellular polarization of microglia, leading to the
formation of body-to-body neuron-glia contacts, called gliapses, which precede neuron elimination.
Inhibiting ROCK/Cdc42-mediated microglial motility in vivo blocks the activating features of microglia,
such as increased cell size and number of filopodia and diminishes their phagocyting/secreting domains, as
the reduction of the Golgi apparatus and the number of microglia-neuron contacts has shown.
High-resolution confocal images and three-dimensional rendering demonstrate thatmicroglia engulf entire
neurons at one-to-one ratio, and themicroglial cell body participates in the formation of the phagocytic cup,
engulfing and eliminating neurons in areas of dopaminergic degeneration in adult mammals.
M
icroglial cells constitute the first barrier of the innate immune response in the brain and are crucial
players in the integrity of the nervous system1. Microglia constantly survey the brain parenchyma and
are able to detect changes in the tissue and rapidly migrate to damaged areas2. The mechanism under-
lying microglial chemotaxis to areas of degeneration requires the release or leakage of ATP from the injured
tissue3, activating P2Y microglial receptors4–6. This signaling is crucial for the microglial migration and invasion.
Specifically, P2Y12 signals microglial activation6, while P2Y6 controls phagocytosis4. Other compounds, such as
the chemokine ligand of CX3CR1, fractalkine, or externalized phosphatidylserine, also play an important role in
the interaction of microglial cells toward damaged neurons and, importantly, the balance of the ligand and
receptor response might define the final fate of the neurodegenerative process7–9.
After migration, the microglia repair the tissue through the release of different factors, such as cytokines,
trophic factors or neurotrophins, and the removal of debris and undesired elements through phagocytosis1.
Previous in vitro studies performed with fluorescent microspheres, opsonized beads or fluorescently labeled b-
amyloid, have shown that microglial cells bind to the prey, forming a phagosome, which fuses with a lysosome to
digest the material10–12. However, imaging studies concerning the details of microglial phagocytosis in vivo are
scarce. Time-lapse confocal microscopy studies in zebrafish have demonstrated that microglia phagocytose
portions of apoptotic neurons during embryo development in vivo through the formation of phagosomes via
v0-ATPase a1-mediated mechanisms13. In addition, the results of detailed confocal analyses have shown that in
the adult hippocampus of mice, the majority of newborn neuroblasts are pruned early during their development
through the phagocytosis at microglial filamentous terminals14. However, apart from the stages of embryo
development13 and the formation of newborn cells14, technical limitations have hindered the characterization
of the involvement of microglial cells in adult mammalian neurodegenerative diseases in vivo. Therefore, under-
standing the mechanisms of the microglial phagocytosis of degenerating neurons in vivo and imaging the details
of the microglial cell migration will be a promising area for research.
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Cell migration has largely been studied in vitro. Motility primarily
reflects the dynamic organization of the actin cytoskeleton, and the
Rho family of small GTPases (i.e., Rho, Rac and Cdc42) critically
regulate this process15. Rho maintains stress fibers and focal adhe-
sion16, while Rac organizes the formation of lamellipodia17 and
Cdc42 promotes the arrangement of filopodia18–20. The majority of
motile and chemotactic cells such as macrophages and most likely
microglia, construct long, thin extensions, called filopodia, which are
supported by tight and dynamic bundles of actin filaments15. This
process also involves the extension of the membrane and filament
elongation, which requires the reorganization of the actin cytoskele-
ton (actin nucleation)15. Importantly, for the cells with phagocytic
properties, Rho and Cdc42mediate the reorganization of stress fibers
and focal adhesion as well as the rearrangement of filopodia21,22.
In 1884, E. Metchikoff defined phagocytosis as the cellular engulf-
ment of large particles, particularly those greater than 0.5 mm, which
also involves dramatic changes in the shape and movement of the
cell. A recent in vitro study of macrophages has shown that the
process of phagocytosis indeed requires the complex arrangement
of the innate immune receptor Dectin-1 at the phagocytic synapse to
bind fractions of small pathogens and form a phagocytic cup of
approximately 4mmwith a particularmicroanatomical shape23; these
results provided insight into the complexity of the engulfing process.
Theoretically, microglial cells might also show similar structures
during phagocytic clearance in neurodegenerative disorders, but lit-
tle data have been published regarding these features. For example, it
remains unknown whether microglia phagocytose small particles or
entire neuronal cell bodies in the neurodegenerative process. In the
context of the development of newborn cells, microglial branches
phagocytose apoptotic neurons forming ‘‘ball-and-chain’’ struc-
tures14,24; however microglia might behave differently in the context
of neurodegeneration, and the details of amoeboid microglia pha-
gocytosis remain elusive.
After decades of research, the significance of microglial activation in
neurodegenerative disorders, such as Parkinson’s disease (PD) and
Alzheimer’s disease25, is multifaceted, and whether this process exerts
a protective or deleterious role remains controversial. To explore the
aspects of microglial function in the neurodegenerative process in
adult mammals and characterize the mechanisms underlying micro-
glial navigation in the brain parenchyma, we have analyzed the micro-
anatomical details of the process of microglial migration-invasion and
phagocytosis in vivo using a model of dopaminergic degeneration
induced through the specific dopaminergic neurotoxin 1-Methyl-4-
phenyl-1,2,3,6-tetrahydropyridine (MPTP). In this study, we observed
that microglia polarize toward intoxicated/damaged dopaminergic
neurons and establish ‘‘gliapses’’ in vivo. The complex intercellular
contacts between microglial cells and neurons might represent a cru-
cial aspect of the neurodegenerative scenario. High-resolution confo-
cal analyses and three-dimensional reconstructions of these contacts
revealed that the anatomical rearrangement of microglial cells involves
the reorganization of the cellular processes, the rearrangement and
enlargement of the Golgi apparatus and the nucleation/clustering of
the actin cytoskeleton. Importantly, we showed that the blockade of
microglial motility, through the inhibition of Rho-associated kinase
(ROCK) activity, prevents microglial polarization/migration and the
formation of gliapses to protect damaged dopaminergic neurons from
elimination. A deeper confocal imaging and 3D rendering revealed
that the gliapse formation by microglial cells resolves in a one-to-one
phenomenon, phagocyting entire dopaminergic neuronal bodies in
the degenerative process. We propose that blocking microglial polar-
ization might preserve degenerating neurons and prevent phagocyt-
osis in PD and other degenerative disorders.
Results
Microglia polarize their processes toward intoxicated/damaged
dopaminergic neurons. Microglial cells constantly survey the
CNS, moving their processes and renewing their terminal tips to
detect changes in the brain parenchyma2; therefore, we investi-
gated this phenomenon in a model of adult neurodegeneration in
vivo. We took advantage of the fact that the pro-neurotoxin MPTP
(metabolized toMPP1) exhibits specific dopaminergic neurotoxicity
in the nigostriatal pathway, inducing the particular activation of
microglial cells detected in the brain parenchyma (Fig. 1A, Fig. S1
and Suppl. Movie 1). In this anatomical area, at 24 h after the
injection of MPTP in C57BL6 mice, Iba-11 microglial cells showed
an activated phenotype characterized by increased cell body size,
accompanied by an increase of the number of terminal tips
(Fig. 1B–C). We hypothesize that this increase of terminals might
reflect the migration of microglial cells toward MPP1-damaged
neurons that exert a ‘‘find-me’’ signal to the surrounding environ-
ment. Therefore, we used high-resolution confocal microscopy to
analyze the physical polarization of microglia in the dopaminergic
pathway and measure the number of actual contacts generated
between microglial cells and dopaminergic neurons (Fig. 1D and
E). We observed that the number of contacts between microglia
and dopaminergic neurons was significantly increased at 24 h after
MPTP inoculation (Fig. 1E), suggesting the arrangement of the first
stage (24 h) of microglial polarization toward damaged neurons. In
addition, at 24 h after MPTP exposure, the surface of contact be-
tween microglia and neurons was also measured, and an increase in
size was observed upon contact with dopaminergic neurites or dopa-
minergic cell bodies (Fig. 1F). Thus, these observations showed that
microglial cells polarize towardMPP1-damaged dopaminergic neur-
ons, suggesting that the motility and rearrangement of the microglial
cytoskeleton occurs concomitantly with microglial activation in
neurodegeneration in vivo.
Blocking ROCK prevents microglial polarization. The small
GTPase ROCK plays a central role in the organization of the
cytoskeleton and it is critically involved in the actin rearrangement
and the movement of the cell15. To determine the role of microglial
polarity in dopaminergic neurodegeneration, we used a potent
ROCK inhibitor, HA-1077, which has been previously used safely
for in vivo experiments and in humans to treat several disorders26.
We did not utilize ROCK knockout mice in these experiments
because these mice exhibit severe developmental problems, such as
the failed closure of the eyelid and ventral body wall, resulting in
open eyes at birth and omphalocele phenotypes in neonates, which
die soon after birth27.
We first analyzed the activity of ROCK using an enzymatic activity
assay to measure the phosphorylation of myosin phosphatase target
subunit 1 (MYPT-1) at threonine 696 (Thr696) and tested the effec-
tiveness of HA-1077 in the nigrostriatal pathway of C57BL6 mice at
24 h after MPTP administration. We observed that the administra-
tion of MPTP significantly increased MYPT-1 phosphorylation in
the nigrostriatal pathway (Fig. 2A), which is significantly abolished
after HA-1077 treatment (Fig. 2A). A detailed study of the micro-
anatomy of microglial cells in the nigrostriatal pathway demon-
strated that the increase in ROCK activity is associated with the
activation of microglial cells, characterized by an increased cell body
size, a higher number of processes (Fig. 2B and C), and increased
expression of F4/80, which is a surface receptor that is augmented
during microglial activation in mice (Fig. S2). Importantly, the
administration of HA-1077 significantly reduced both the microglial
cell body size and the formation of the new terminal processes after
MPTP administration (Fig. 2C). However, HA-1077 did not affect
the MPTP-induced increased expression of F4/80; this finding sug-
gests that the expression of F4/80 in microglia after MPTP insult is
independent of ROCK-mediated mechanisms (Fig. S2). Most
importantly, HA-1077 administration completely abolished the
formation of MPTP-induced microglial contacts with dopaminergic
neurons in the nigrostriatal pathway (Fig. 2D), suggesting that
www.nature.com/scientificreports
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ROCKmight play a critical role in modifying the arrangement of the
microglial actin cytoskeleton in neurodegeneration. Based on this
observation, we assessed the involvement of Cdc42 as this molecule
acts as a center of cell polarity20, and is intimately associated with the
contractility and rearrangement of the actomyosin cytoskeleton and
the phosphorylation ofMYPT-1 (Thr696)28.Western blot analyses of
Cdc42 were performed using brain homogenates prepared from
MPTP-treated mice. We observed a significant increase of Cdc42
in the nigrostriatal pathway at 24 h after MPTP administration,
which was completely reverted after HA-1077 administration
(Fig. 2E and F), thereby demonstrating the in vivo convergence
and cooperation of Cdc42 and ROCK signaling in cell invasion
and motility, as previously shown in vitro28.
A specific actin cytoskeleton rearrangement is observed in
microglia. To further explore the arrangement of the actin
cytoskeleton in microglia, sections containing the nigrostriatal
pathway were stained with phalloidin to detect F-actin and with an
antibody against Cdc42. Because F-actin and Cdc42 are ubiquitously
expressed, confocal analyses in single optical sections revealed that
all cell types showed phalloidin1 and Cdc421 staining (Fig. S3).
Detailed confocal analyses revealed that F-actin and Cdc42 were
Figure 1 | Microglial cells polarize their processes toward neurons afterMPTP. (A) Confocal images of the SNpc show the activation of microglial cells,
characterized through the increase of their cell body size and the higher number of terminal tips in close apposition to dopaminergic neurons afterMPTP
treatment. (B) The confocal pictures from the SNpc were analyzed in detail and representative illustrations of the cells were delineated based on the
confocal images. Scale bar in A and B: 50 mm. (C) The number of terminal tips of microglial cells increased after MPTP treatment. *p,0.05.
(D) Microglial cell processes and cell bodies are in contact with dopaminergic neurites and dopaminergic cell bodies. (D1) Confocal image showing
microglial cells (green) contacting their processes with dopaminergic neurons (red). Cell nuclei are counterstained with DAPI (blue). Arrows indicates
contacts with dopaminergic cell bodies or neurites. Scale bar in 1: 25 mm. (D2) A microglial cell body in contact with a dopaminergic neurite. (D3) A
microglial cell body in contact with a dopaminergic neuron cell body. Scale bar in 3: 20 mm. (E) The number of microglial cells processes in contact with
dopaminergic processes [Pr-Pr] and with dopaminergic cell bodies [Pr-B] increases after MPTP treatment. The contacts between microglial cell bodies
and dopaminergic structures (B-Pr and B-B) were not modified. (TOTAL/Pr5[Pr2Pr]1[B2Pr]), TOTAL/Ne5[Pr2B]1[B2B]. *p,0.05 (F)
Quantification of the length of the contact between microglial processes and dopaminergic neurites or dopaminergic cell bodies increases after MPTP
treatment. *p,0.05, **p,0.01.
www.nature.com/scientificreports
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clustered specifically in microglial cells, either in control or Par-
kinsonian mice, which showed the cytoplasmic accumulation of
relative fluorescence compared with surrounding cells (Fig. 3A, B
and Fig. S3). The clustering and rearrangement of F-actin and Cdc42
in microglial cells are consistent with the constant motility and rapid
cytoskeletal rearrangement of these cells during their surveillance of
the CNS, as opposed to other cell types, such as astrocytes or neurons,
which are slower or almost static2,29. However, the confocal analysis
of microglial cell interactions with dopaminergic neurons revealed
that actin clusters polarize toward the interface of the microglia-
neuron contact at the protrusion (Fig. 3D, D and Fig. S3). In
addition, sections of the nigrostriatal pathway revealed that Cdc42
is also specifically concentrated in the lamiellipodial protrusion
(actin-rich lamella) of polarized microglia (Fig. 3 and Fig. S4),
Figure 2 | Blockade of ROCK prevents microglial polarization. (A) HA-1077 inhibits the increase of ROCK activity induced by MPTP. *p,0.05
compared with the control. (B) Top panel shows representative confocal pictures of Iba-1 at the level of the SNpc of the four different groups. Bottom
panel shows illustrations of two representative microglial cells from each group obtained from the Iba-1 confocal images. (C) The polarization of
microglial cells induced throughMPTP treatment is abolished via the specific ROCK inhibitor HA-1077. The increased microglial size and the increased
number of microglial processes induced through MPTP treatment are diminished via the specific ROCK inhibitor HA-1077. *p,0.05, **p,0.01 with
respect to the control. (D) The increased number of contacts between microglial processes and dopaminergic neurites (Pr-Pr) and cell bodies (Pr-B)
induced throughMPTP treatment is abolished with specific ROCK inhibitorHA-1077. (E)Western immunoblot of Cdc42 in the nigrostriatal pathway of
mice treated with saline, HA-1077, MPTP orMPTP1HA-1077. Human platelet extract (HPE) was used as a control signal for Cdc42. (F) Quantification
of the optical density of Cdc42 normalized with GAPDH. Note that HA-1077 inhibits the increase of Cdc42 induced through MPTP treatment, as
measured using Western Blot **p,0.01, *p,0.05 compared with the control.
www.nature.com/scientificreports
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similar to the clustering of F-actin, as shown above. These obser-
vations suggest that HA-1077 blocks the MYPT-1 phosphorylation
at Thr696 and might inhibit the process of microglial polarization at
the level of ROCK and Cdc42 during lamella formation.
Blocking ROCK prevents neuron elimination and body-to-body
(gliapse) formation. To explore the effect of blocking ROCK-
dependent microglial polarity on neuronal degeneration, we
performed an MPTP intoxication experiment in mice sacrificed at
Figure 3 | F-actin and Cdc42 is highly clustered in microglial cells. (A) Stack of confocal sections of the nigrostriatal area immuno-stained for Iba-1
(green), stained with 633-phalloidin (Magenta) to label F-actin, and counterstained with DAPI (blue) in a MPTP-treated mouse. In the Overall view,
because F-actin is ubiquitous, high exposure to infrared 633-nm laser displays the positive stain of the tissue but hampers the appreciation of details.
However, low exposure to the 633-nm laser reduces the intensity of the general F-actin staining and facilitates the appreciation of high fluorescent clusters.
Panel on the center shows the Detail of these stacks of images. F-actin highly fluorescent clusters are observed in microglial cells but not in the rest of
neighboring cells. Panel on the right shows theZ-axis view,which facilitates the identification of the specific clustering of F-actin inmicroglia. (B) Stack of
confocal sections of the nigrostriatal area immuno-stained for Iba-1 (green) andCdc42, and counterstainedwithDAPI (blue) in anMPTP-treatedmouse.
In theOverall view because Cdc42 is also ubiquitous, high exposure to the 594-nm laser shows the general immuno-staining of the tissue but impedes the
appreciation of the details. However, low exposure to the 594-nm laser reduces the intensity of the general Cdc42 staining and facilitates the appreciation
of highly fluorescent clusters. The Detail of these stacks of images in the central panel shows that Cdc42 highly fluorescent clusters are observed in
microglial cells and not in the rest of neighboring cells. The Z-axis view on the right panel facilitates the identification of the specific clustering of Cdc42 in
microglia. The arrows indicate representative microglial clusters. (C) Confocal analysis of polarization and clustering of F-actin in a microglial cell
contacting a dopaminergic neuron after MPTP injection. F-actin cluster appear at the protrusion of polarized microglial cells toward the dopaminergic
cell body. (D) Explicative diagram of the image from C.
www.nature.com/scientificreports
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three different timewindows (24, 48 and 72 h afterMPTP) to observe
a quantifiable and evident neuronal death after the administration of
MPTP. Importantly, we observed that blocking ROCK through
HA-1077 administration prevents MPTP-induced neuronal dege-
neration, as measured by the quantification of TH1 and Nissl1
neurons, indicating that ROCK-mediated microglial cell polarity in
vivo might be necessary for neuron elimination (Fig. 4A, B and
Fig. S5A).
The detailed analysis of the microglia-neuron contacts at these
time points revealed an increase of the ‘‘microglial cell body-neur-
onal cell body’’ contacts that precede neuron degeneration, suggest-
ing that this contact might be critical for neuronal elimination
(Fig. 4C and D). Interestingly, the number of one-to-one body-to-
body contacts increased nearly 0.2, indicating that 20% of the dopa-
minergic neurons showed gliapses at 48 h after MPTP treatment.
This percentage is consistent with the amount of dopaminergic neur-
onal loss observed at 72 h, which is nearly 25% of the dopaminergic
neuronal loss compared with the control. Moreover, to exclude the
possibility that the preservation of SNpc dopaminergic neurons does
not reflect the absence or decrease of MPP1 in the nigrostriatal
pathway, HPLC was used to measure MPP1 showing that HA-
1077 administration does not impede the entrance of MPP1 into
the dopaminergic pathway (Fig. S5B).
Micro-anatomical analysis reveals the phagocytic character of
Gliapses. A microanatomical analysis of the neuron-microglia
body-to-body contacts after MPTP administration revealed
immunological synapse-like structures between the microglia and
neuron, herein referred to as ‘‘gliapses’’, which represent a new
concept based on the anatomical relationship between glial cells
and neurons that was originally described in the electrophysi-
ological context of neurotransmission30. The anatomical body-to-
body engagements (gliapses) between microglia and dopaminergic
neurons that we observed after MPTP treatment share some ele-
ments with T cell-APC immunological synapses. Three-dimensional
reconstructions of the captured stacks of images revealed that one of
the key features of these engulfing gliapses, which represents the flat
interface between the two cell bodies, is a structure reminiscent of
lymphocyte-target cell immunological synapse (Fig. 5). However, in
contrast to lymphocytes, the microglial cells presented long thin
filopodial processes, which participate in gliapse formation and
frequently embrace the neuronal cell bodies after MPTP (Fig. 5A–
D). In addition, these microglial processes are reduced in number or
completely absent from the side of the cell that was not in apposition
to the neuron cell body, and most microglial processes were
polarized, contacting the neuronal cell body (Fig. 5B and D). In
addition, confocal three-dimensional rendering showed that the
Figure 4 | HA-1077 treatment prevents gliaptic body-to-body contacts and neuron elimination. (A) Quantification of the number of dopaminergic
neurons of the SNpc of mice treated with Saline (Control), MPTP, HA-1077 or MPTP 1 HA-1077. The treatment with HA-1077 prevents the
dopaminergic degeneration induced byMPTP. (B) Representative images of immuno-staining for TH1 neurons to observe dopaminergic neurons of the
SNpc of a representative mouse of each experimental group analyzed. (C) Illustration of a characteristic gliaptic body-to-body contact betweenmicroglia
and TH neurons. The augmented detail of the merged image is shown rotated in the vertical picture. (D) Quantification of the number of body-to-body
contacts between dopaminergic neurons and microglial cells of the SNpc of mice treated with Saline (Control), MPTP, HA-1077 or MPTP1HA-1077.
The formation of body-to-body contacts precedes neuronal degeneration and conversely treatment with HA-1077 prevents the formation of body-to-
body contacts after MPTP treatment.
www.nature.com/scientificreports
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Golgi apparatus was also polarized at the interface, suggesting
secretory or phagocytic domains of these gliapses (Fig. 5E and F).
Because the size of the Golgi apparatus fluctuates with secretory and
phagocytic activity, we also measured the size of the Golgi apparatus
in the microglia from mice after MPTP treatment in the SNpc. We
observed that the size of microglial Golgi increases after exposure to
MPTP, an effect that is indeed reversed with ROCK inhibition
(Fig. S6).
Importantly, evidence from captured images and 3D rendering
show that microglial cells engulf entire neuronal bodies, showing a
clear phagocytic appearance (Fig. 6A, images 1, 19, 2, 29 and Suppl.
Movie 2). In these events, the TH labeling is weak where microglial
cells surround a big percentage or the entire dopaminergic cell body;
the neuronal cell body becomes smaller (Fig. S7), and the nucleus
appears condensed, suggesting that these gliapses might become
phagocytic synapses (Fig. 6A, images 2 and 29). Importantly, a fur-
ther detailed micro-anatomical analysis showed frequent and strik-
ing structures, which are only present in the SNpc after MPTP
administration and were not detected in the rest of the dopaminergic
pathway (Suppl. Movies 3a and 3b). Single microglial cells fre-
quently appear surrounding an extra nucleus, which presents pyc-
notic features, such as the condensation or fragmentation of
chromatin (Fig. 6A, images 3 and 39, B–D, Fig. S8 and Suppl.
Movie 4). This engulfed extra nucleus is located in an ‘‘Iba-1 negative
space’’, with the appearance of amicroglial endosome, suggesting the
formation of a microglial phagosome engulfing a dopaminergic neu-
ron (Fig. 6D and E and Suppl. Movies 5a, 5b and 6). To demonstrate
the phagocytic character of this microglial cells, we stained these
structures with antibodies against Cathepsin-D, which specifically
localizes to lysosomes. We observed Cathepsin-D1 lysosomes in
microglial cells consistently localized in the vicinity of the microglial
nucleus in proximity to phagosomes containing the extra nucleus
(Fig. 7A–E); this finding suggests that this giant phagosomemight be
eliminated through phagocyticmicroglia via the formation of smaller
phagolysosomes. To further explore the state of actin in this pha-
gocytic state, we also stained brain sections with phalloidin and
observed a clear clustering of F-actin near the microglial nucleus in
all cases (Fig. 8A–B and Suppl. Movie 7). However, the orientation
of the F-actin accumulation was variable (Fig. 8) and did not have a
clear polarization. Although the clustering of F-actin ismaintained in
the engulfing process, it appears to migrate away from the interface
between the microglial nucleus and the giant phagosome.
Discussion
In the present work, we showed that microglial cells polarize and
contact MPP1-damaged dopaminergic neurons, forming complex
intercellular appositions, gliapses, that lead to the phagocytosis of
dopaminergic cell bodies. This process of cellular invasion/migration
is ROCK-dependent and involves the actin cytoskeleton; impor-
tantly, the inhibition of this process prevents the elimination of
Figure 5 | Microanatomy of engulfing gliapses formation in the SNpc of Parkinsonian mice. (A) Image of a gliapse in the SNpc of an MPTP-treated
mouse (Giapse 1). Themicroglial cell (red) is in close apposition with a dopaminergic neuron (white) and its processes are polarized to the dopaminergic
neuron cell body. (B) Three-dimensional rendering of Gliapse 1. (C) Image of gliapse formation in the SNpc of an MPTP-treated mouse. (D) Three
dimensional rendering of Gliapse 2. (E) Analysis of polarization of Golgi and Iba-1 at the engulfing gliapse. Optical sections (0.5 mm thick) fromGliapse 2
are shown in the top row. Immunofluorescence for the Golgi apparatus (GM130, green), microglia (red) and TH (white) are displayed, together with
nuclear counterstaining using DAPI (blue). GM130 is arranged at the interface. The bottom row shows the details of the interface area. Iba-1 appears
polarized toward the dopaminergic neuron (1). Microglial GM130 is polarized only on the side of the cell in contact with the dopaminergic neuron (2, 3).
GM130 occupies the area of the intercellular interface (4, 5). Ratio of the physiological activity analysis of the channels shows themaximum activity at the
engulfing gliapses interface (6). (F) Confocal analysis of the polarization of Golgi in the xy plane and along the z-axis. Polarization of GM130 can be
observed in the lateral views along the z-axis scanning. Scale bar in A; 25 mm, in B; 15 mm.
www.nature.com/scientificreports
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dopaminergic neurons. Our high-resolution images showed that the
entire microglial cell body participates in the formation of the pha-
gocytic cup differently from the smaller phagocytic cups formed in
the engulfing of small pathogens23 and differently from the elimina-
tion of newborn cells in which only the microglial branches are
involved in the phagocytic process, forming a ball-and-chain struc-
ture14. In our model, phagocytosis is a one-to-one process and the
microglial cell body apposes the neural cell body with its processes
oriented toward the neuron. The engulfing microglia forms a giant
phagosome (20 mm diameter) containing a single neuron, with clear
pycnotic characteristics, and contains Cathepsin-D1 lysosomes in
well-determined areas of the microglial cytoplasm, indicating active
phagocytosis.
It is reasonable to propose that microglia cells send ‘‘find-me’’ and
‘‘eat-me’’ signals, which might be ATP-dependent, involving P2Y
receptors during the first stages of polarization, as has previously
established4,6. In addition, it is likely that the secretion or leakage
of ATPmight be a sufficient stimulus to directmicroglial cells toward
damaged neurons, activating ROCK signaling and initiating
movement and polarization. We showed that ROCK signaling
involves the phosphorylation of MYPT-1 at Thr696 in vivo, as
demonstrated using an enzymatic activity assay, and this phosphor-
ylation is associated with the Cdc42 cascade, which shares the same
domains in cell polarization and actin cytoskeleton rearrangement28.
Importantly, our study demonstrates that ROCK inhibition
diminishes most microglial activation properties, such as the
increased cell body size, number of filopodial processes and size of
Golgi apparatus, after MPTP insult. In contrast, ROCK inhibition
does not reduce the MPTP-induced increase of F4/80 expression in
microglial cells, suggesting that this latter feature ofmicroglial activa-
tion is independent of ROCK-mediated mechanisms, indicating that
microglial cells receive activation signals from the MPP1-damaged
neurons and consequently over-express F4/80, even when their mot-
ility is blocked by HA-1077. This observation is consistent with
previous studies performed in F4/80 knockout mice, where the mot-
ility and distribution of the macrophages in the organism remained
unaffected, while the recognition of pathogens and the induction of
antigen-specific efference wasmarkedly altered31. These results show
Figure 6 | Microglial cells phagocyte degenerating neurons in the SNpc (A) Confocal images of engulfing events in the SNpc of mice after MPTP-
treatment. Microglial processes engulfing a dopaminergic neuron after MPTP treatment (1, 19, 2, 29). Engulfed dopaminergic neurons present a smaller
size, low intensity of TH and pycnotic nuclei (2, 29). Microglial cells engulfing pycnotic nuclei (3, 39). (B) Diagrams of the three events described in A (10,
20 and 30). (C) The subtraction of the black background in the engulfing gliapse shown in 2 and 20 facilitates the observation of the pycnotic nature of the
nucleus of the neuron, the punctuated TH staining and the shape of the engulfed dopaminergic neuron. (D) Lateral view of the z-axis of an engulfing
microglia. Note that the pycnotic extra nucleus is completely surrounded by the Iba-11 membrane. (E) Three-dimensional reconstructions of engulfing
microglial cells in the SNpc after MPTP treatment. In both examples, the extra nucleus is completely surrounded by the membrane of the microglial cell.
The clipping plane (yellow) is shown at the level of the extra nucleus. (F) Overhead view of a three-dimensional reconstruction of a microglial cell
engulfing an extra nucleus in the SNpc of a mouse after MPTP treatment in the SNpc.
www.nature.com/scientificreports
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that motility and F4/80 expression are two independent pathways in
the process of macrophage/microglia activation.
According to our results, the process of microglial polarization in
dopaminergic neurodegeneration undergoes different steps in adult
mice, beginning with the polarization of filopodial processes toward
neurons (occurring at 24 h after MPTP treatment), followed by the
polarization/migration of the microglial cellular body (occurring
48 h after MPTP). These data illustrate the velocity of the approach
of the microglial cell to the damaged dopaminergic neuron after
MPTP administration, which suggests that microglial cells might
have a specific time window, within 24 h, to recognize the state of
the neuron and ‘‘decide’’ and resolve its final fate. Importantly, our
data show that body-to-body (B-B) contacts are increased at 48 h
after MPTP and precede the neuron elimination observed at 72 h,
suggesting that the elimination of dopaminergic neurons requires
prior gliapse formation followed via microglial phagocytosis.
Our images show that microglial cells engulf cells with clear pyc-
notic nuclei and an apoptotic appearance. The time-frame quantifi-
cations suggest thatmicroglial cells pursue degenerating neurons and
digest entire cell bodies during MPP1-induced damage is ongoing.
Gliapse body-to-body formation precedes neuron elimination and
does not take place at 72 h after the MPTP administration, suggest-
ing that the degenerating process is resolved during this time frame.
Although in ourmodel we are certain thatMPP1 is the primary cause
of the dopaminergic neurotoxicity, the engulfing process might also
influence the neuronal degeneration and the apoptotic and con-
densed appearance of the nuclei. Recent data demonstrate that pha-
gocytosis alone induces cell death. New reports have provided
evidence that microglial phagocytosis might be a phenomenon for
the induction of neuronal death32 and promotion of apoptotic cell
corpse degradation33; thus, in our scenario, the occurrence of the two
phenomena as well as the toxicity of MPP1 and active phagocytosis
might all participate in dopaminergic body degradation and the
formation of the pycnotic nuclei.
Other cells from the blood stream could infiltrate the brain par-
enchyma to repair the tissue damage. Peripheral monocytes/macro-
phages infiltrate from the blood stream to the brain parenchyma.
Previous studies have shown that, in similar protocols of acute
Figure 7 | Localization of lysosomes in engulfing microglia. (A) Confocal analysis of an engulfing microglial cell stained with Lectin (red), showing
Cathepsin-D1 lysosomes (green) in the SNpc of a mouse treated with MPTP. DAPI (blue) was used as a counterstaining. (B) Lateral view of the extra-
nucleus inside the microglial phagosome from A. (C) Detail of Cathepsin-D1 lysosomes close to the microglial nucleus. The images were treated with a
surface filter to better appreciate the cellular structures. (D) Examples of engulfingmicroglia with Cathepsin-D1 lysosomes. An image filter was applied to
highlight the contours in the three examples. (E) Detailed confocal analysis of an engulfing microglia showing a kidney-shaped nucleus surrounding the
Cathepsin-D lysosome. The pycnotic engulfed extra nucleus can also be clearly observed with the DAPI counterstaining.
www.nature.com/scientificreports
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parkinsonization, MPTP administration does not initially increase,
but rather paradoxically, decreases, specific macrophage infiltration
in the SNpc34. However, the results of long-term experiments with
MPTP administration have shown that infiltrated monocytes might
present microglial phenotype and express microglial markers in the
SNpc several weeks (60 days) after the initial MPTP inoculation but
not in the early days after the parkinsonization35. These results clarify
that the process observed in the present study, within 72 h, is most
likely performed through resident microglia and not other infiltrated
monocytes or macrophages.
Theoretically, the phagocytosis performed through healthymicro-
glia is a necessary and beneficial process to isolate a dead neuronal
cell body and avoid tissue damage that might cause in the par-
enchyma. Therefore, on one hand, the use of ROCK inhibitors as a
therapeutic tool might apparently represent a problem because the
consequences of keeping non-phagocytosed MPP1-damaged dopa-
minergic neurons remain unknown, and their long-term physio-
logical functionality might be questioned. However, on the other
hand, increasing evidence has shown that microglia might be inap-
propriately active in PD patients, and therefore blocking microglial
cell activity could be beneficial. Indeed, previous studies have shown
that microglia phagocytose viable neurons in a neuro-inflammatory
environment and induce apoptosis9,32, suggesting that phagocytosis
might be an important factor for the understanding of the neuro-
degeneration of PD. In addition, dopaminergic neurons are espe-
cially vulnerable to inflammation, and these responses might be
crucial in aggravating dopaminergic degeneration in the SNpc36. In
fact, recent findings have demonstrated that human leukocyte anti-
gen complex-DR (HLA-DR) gene polymorphisms are linked to the
late onset idiopathic PD, suggesting an inflammation-related origin
Figure 8 | Actin clustering in engulfingmicroglia. (A) F-Actin accumulation can be observed in the vicinity ofmicroglial nucleus in engulfing gliapses in
the SNpc of Parkisonian mice. Two examples of gliapses are shown, where a microglial cell engulfs an extra nucleus and shows F-actin accumulation
(arrows). Higher magnifications of the F-actin accumulation are shown in 1, 19, 2 and 29. Explicative diagrams are shown on the right. (B) Example of F-
actin accumulation in other engulfing gliapse. Higher magnifications of the F-actin accumulation are shown in 3 and 39. In this case, the extra nucleus is
located at a different optical plane and the lateral view along the z-axis is shown in D. In all three gliapses actin clusters are moved away from the interface
phagosome-microglial nucleus. (C) The 3D analysis of the level of relative fluorescence of F-actin in the three gliapses studied. The maximum level of F-
actin fluorescence was detected specifically in the engulfing gliapses (magenta arrows). (D) Lateral z-axis view and three-dimensional reconstruction of
Gliapse 3. Overview of the 3D reconstruction is shown in 1. The clipping plane at the level of F-actin accumulation of the 3D reconstruction is shown in 2.
The yellow insert in 2 is magnified in 3.
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of the disease involving microglia37. Precisely, HLA-DR is the same
antigen that is over-expressed in activated microglial cells in PD25
and MPTP-intoxicated humans38 and non-human primates39.
Consistent with this notion, glial-mediated sustained neuro-inflam-
mation might be harmful for the surrounding parenchyma, and the
putative negative effect of microglia in PD, might exacerbate the pro-
inflammatory response and an overly activated phagocytic arm.
Therefore, treatment with anti-inflammatory drugs has been sug-
gested as a preventive therapy for neurodegeneration40. Indeed,
blocking motility through ROCK inhibitors might represent a po-
tential strategy to diminish microglial-mediated inflammatory res-
ponses, specifically preserving neurons frommicroglial phagocytosis
and therefore preventing their complete elimination. Importantly,
because microglial activation is aggressively initiated in early PD41
but remains stable for years42, it is essential to consider that treatment
with ROCK inhibitors might be relevant in the first stages of the
disease to prevent glial-mediated inflammation and neuronal elim-
ination.
In conclusion, in the context of neurodegeneration, where the
phagocytic domain might be exacerbated, microglia could also elim-
inate neurons unnecessarily and create a pathological environment
in which blocking reactive microglia with ROCK inhibitors could be
justified and beneficial, at least to preserve neurons from phagocytic
elimination. ROCK inhibitors might be a promising alternative for
the treatment of some neurodegenerative diseases, such as PD26, and
further basic and clinical research is needed to enhance the current
understanding of the function ofmicroglia and inflammation in both
experimentalmodels and patients to evaluate the therapeutic benefits
and determine the favorable targets to administer effective disease-
modifying drugs.
Methods
MPTPmice and ROCK inhibitor treatment. Adult male mice C57BL/6J (ten weeks
old) were purchased at JaxHMice (The Jackson Laboratory, Bar Harbor, Maine USA)
and housed in a special room under adequate temperature (21uC) and 12 hour day-
night cycles. Themice were injected (via intraperitoneal injection) either with a single
dose of 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) hydrochloride
(Sigma-Aldrich) (20 mg/Kg) dissolved in saline, or the same volume of saline, or the
ROCK inhibitor HA-1077 (Sigma-Aldrich), or a combination of HA-1077 1 MPTP,
and sacrificed at 24, 48 or 72 h after the single dose (at least n55 per group). HA-1077
was also dissolved in saline and injected intraperitoneally in a single dose (40 mg/Kg)
at 30 minutes prior to MPTP administration. All mentioned studies performed in
mice were conducted in accordance with the regulations of the state members of the
European Union (2003/65/CE), the Guidelines of the European Convention for the
protection of Vertebrate Animals used for Experimental and other scientific purposes
of the Council of Europe (no. 123, June 15th, 2006), the European Communities
Council Directive 2010/63/ECC, and the National Institutes of Health Guide for the
Care and Use of Laboratory Animals (NIH Guide, revised 1996). In addition, the
Committee of Ethics of the University of Murcia approved the protocols and
experiments described in the project SAF2010-21274.
Western immunoblot. Primary antibodies. To asses changes in Cdc42 in the
nigrostriatal pathway of mice a western immunoblot was performed with anti-Cdc42
diluted 15500 (Cytoskeleton, Denver, CO, USA). The GAPDH antibody was used to
determine the housekeeping of each sample (mouse anti-GAPDH, 15500, Chemicon,
Temecula, CA, USA).
Preparation of tissue extracts. C57BL6 mice were injected either with saline (n55),
MPTP (n55), HA-1077 (n55) or MPTP1HA-1077 (n55), according to the pro-
tocol described above. At 24 h after the treatment, the mice were sacrificed through
cervical dislocation. The brains were quickly harvested on ice, frozen and cut into 1-
mm-thick sections with the aid of a matrix for brain slicing. The striatum and the
Substantia Nigra pars compacta (SNpc) were dissected according to the appropriate
coordinates in the mouse brain atlas43 using a punching device (Harvard apparatus,
Harvard bioscience company) with a 1-mm internal diameter and a thin needle,
respectively. The tissues were immediately homogenized using a disposable pellet
pestle (Sigma-Aldrich, St. Louis, MO, USA) in RIPA buffer, containing 50 mM Tris/
HCl pH 7.6, 150 mM NaCl, 1 mM EDTA, 1% SDS, 1% Triton X-100, a 1X cocktail
inhibitor (Sigma-Aldrich, St. Louis, MO, USA), 1 mM PMSF, 0.2 mM Na3VO4 and
1 mM NaF. After centrifugation (15,000Xg for 15 minutes at 4uC), a sample of the
supernatant was analyzed to determine the total concentration of the protein in the
sample using the Micro BCA kit (Pierce, Rockford, IL, USA). Other aliquots of the
samples were mixed with 4x reducing loading buffer (200 mM Tris/HCl pH 6.8, 4%
SDS, 30% glycerol, 4% b-mercaptoethanol, 4% blue bromophenol), boiled for 3
minutes and stored at -20uC until further use.
Electrophoresis and immunoblotting. For each sample, 80mg of proteins was separated
in a 12% SDS-polyacrylamide gel. The molecular mass standard (ColorBurstE,
Sigma-Aldrich, St. Louis, MO, USA) containing precisely sized recombinant proteins
of 210, 90, 65, 40, 30, 20, 13, 8 kDa, human platelet extract as a control for Cdc42
signal (40 mg) (Cytoskeleton, Inc.), and the samples of the nigrostriatal pathway were
run on the same gel and transferred onto a nitrocellulose membrane. The samples
were run at constant voltage (200 mV) at room temperature (RT) for 1 hour. After
electrophoresis, the protein samples were transferred onto a nitrocellulosemembrane
using a transfer buffer (25 mM Tris/HCl, 192 mM glycine, 0.1% SDS, 20% meth-
anol). Ponceau S staining (Bio-Rad, Hercules, CA, USA) was used to verify equal
protein loading in all the lanes. Non-specific biding sites were blocked upon
incubation in 5% dry milk diluted in 1X TTBS (20 mM tris/HCl pH 7.5, 500 mM
NaCl, 0.05% tween-20) for 2 h at RT. The membranes were incubated overnight at
4uC in primary antibody diluted in 3% BSA, 0.05% NaN3, in 1X TTBS. After rinsing
twice with 1X TTBS and 3 times with 2.5% drymilk in 1X TTBS, themembranes were
incubated for 1 h at RT in ECL sheep anti mouse IgG, horseradish peroxidase con-
jugated secondary antibody (Amersham, GE healthcare, Little Chalfont,
Buckinghamshire, UK) diluted 155,000 in 2.5% dry milk in 1X TTBS. The antibody
binding sites were revealed using the ECL Plus Western Blotting Detection System
(Amersham, GE healthcare, Little Chalfont, Buckinghamshire, UK).
The intensity of the bands was evaluated through densitometry analysis using
ImageJ 1.41 software. The optical density of each protein band was normalized
against the optical density of the GAPDHband, used as internal standard, in the same
lane. For each independent experiment the differences between the experimental
groups were expressed as treated/ctrl. The graphs represent the average of the ratios
calculated from five independent experiments6 SEM. AOne-WayANOVADuncan
test was used to determine the p value. Differences were considered significant when
p#0.05.
RhO-associated kinase (ROCK) Activity Assay. C57BL6 mice were injected either
with saline (n55), MPTP (n55), HA-1077 (n55) or MPTP1HA-1077 (n55),
according to the protocol described above and following the same procedure of tissue
extract described for western immunoblot analysis. The ROCK activity was analyzed
using a 96-well ROCK activity assay kit (Cell Biolabs, INC., CA, USA). The
experiments were performed according to the manufacturer’s protocol, using 10 ml
of protein lysate. The total starting protein concentration for every sample was 1 mg/
ml. The activity of ROCK was measured by quantifying the level of phosphorylation
of MYPT-1 in Thr696. Briefly brain lysates were placed in MYPT-1-coated wells and
incubated during 60 minutes at 30uC. After washing, incubation of anti-Phospho-
MYPT-1 (Thr696) antibody was conducted for 1 h. After washing, the HRP-
conjugated secondary antibody was added. After a 1-hour incubation, the plates were
washed, and the substrate solutionwas added for 10minutes and theODwas read in a
microplate reader capable of reading at 450 nm (620 nm was used as reference wave
length).
Tissue and specific staining. Mice. C57BL6 mice were injected either with saline
(n515),MPTP (n515), HA-1077 (n515) orMPTP1HA-1077 (n515), according to
the protocol described above. One, two or three days after MPTP injection, mice
(n55 per group and time point) were anesthetized i.p. with an overdose of Ketamine
(50 mg/kg) and Xylazine (50 mg/kg) and perfused-fixed with oxygenated Tyrode’s
solution followed by 4% paraformaldehyde in PBS. Brain tissue was removed and
post-fixed for 48 h before sectioning and further analysis.
The striatum and mesencephalon were sectioned into 40 mm thick serial sections
(Vibratome, Leica). Series of sections regularly spaced were stained with antibodies
anti-tyrosine hydroxylase (TH) (sheep polyclonal antibody 15500; Chemicon,
Temecula, CA, USA), anti-Iba-1 (rabbit polyclonal antibody 15500;Wako, Chuo-Ku,
Osaka, Japan), anti-Cdc42 (mouse monoclonal 15200; Cytoskeleton, Denver, CO,
USA), anti-GM130 (mouse monoclonal 15500; Abcam, Cambridge, UK), anti-
Cathepsin-D (rabbit polyclonal 1550; Cell Signaling Technology, Danvers, MA).
Since Iba-1 staining was incompatible with Cathepsin-D, in order to localize
Cathepsin-D in microglial cells, rhodamine-conjugated tomato lectin (Griffonia
Simplicifolia Lectin I, 15100, Vector, Burlingame, CA, USA) labeling was performed
to detect microglial cells.
Immunohistochemistry and immunofluorescence. DAB detection. Sections of the
SNpc (40 mm) were used for immunohistochemistry to detect specific cells and
structures. Endogenous peroxidase activity was inhibited with 0.3% H202, and non-
specific Fc binding sites were blocked with 10% horse serum. The sections were
incubated for 48 h (room temperature, constant shaking) with primary antibody (see
above) diluted in PBS containing 1% horse serum, 0.5% Triton X-100, and 0.1%
sodium azide. The sections were incubated for 4 h in secondary antibody diluted in
antibody solution. Binding of antibody was detected with avidin-biotin peroxidase
ABC kit (Vectastain, Vector Labs). The sections were mounted on gelatin-coated
slides and dehydrated in graded ethanol series and xylene before being coverslipped.
Immunofluorescence. For immunofluorescence, 40 mm sections were treated with
0.5% citrate buffer (65uC, with constant shaking) for 30 minutes to maximize anti-
body penetration into tissue. Non-specific Fc binding sites were blocked with 10%
horse serum, and the sections were incubated for 48 h (room temperature, constant
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shaking) with primary antibody diluted in PBS containing 1% horse serum, 0.5%
Triton X-100, and 0.1% sodium azide. The sections were incubated for 4 h in labeled
secondary antibody; after PBS washes, the sections were incubated with DAPI solu-
tion (151,000) in 1X PBS for 30 minutes. Then, the sections were washed, mounted,
and examined for quantification of fluorescence (Zeiss Axioplan 2) or using confocal
microscopy (Leica DMIRE2). Appropriate secondary antibodies were used: Alexa
488-conjugated, Alexa 594-conjugated or Alexa 647-conjugated (151,000)
(Molecular Probes). For F-actin staining, the sections where incubated with Alexa
Fluor 488-phalloidin or 647-phalloidin (15500 in PBS;Molecular Probes) during two
hours at room temperature after immunostaining. After washing, the sections were
incubated with DAPI solution for 30 minutes. The sections were washed again,
mounted and examined by microscopy for normal fluorescence (Zeiss) and analyzed
with confocal microscope (DMIRE2, Leica Microsystems, Exton, PA).
Quantification and sterological analysis. The nigrostriatal pathway was defined
according to the Mouse Brain Atlas43. Quantification of DAB or fluorescently
labeled cells in the striatum was performed on coronal sections in series from each
animal. The number of cells was estimated with optical fractionator probe using a
computer assisted image analysis system with a Zeiss Axioplan 2 microscope con-
trolled connected to a digital camera. The region of interest was traced using the 1.25 x
objective. The number of cells was measured in 2003 200 mmdissectors covering the
surface of the analyzed region. Labeled cells were counted using the 40x objective with
counting frames throughout the delineated area of the SNpc in each section via the
optical fractionator. Four serial sections of the SNpc were used for each staining in
mouse brain. Data were expressed as an absolute number of positive cells in each
anatomical region analyzed. Results were expressed as the mean 6 SEM.
Confocal analysis and 3D rendering.The brain sections were examined using a Leica
DMIRE2 confocal microscope with the 63x oil objective and Leica Confocal Software
(Leica Microsystems). Series of optical sections were performed determining an
upper and lower threshold using the Z/Y position for Spatial Image Series setting. The
optical series covered 20 mm of thickness through the tissue with 0.5 mm per optical
section. The confocal microscope settings were established and maintained by Leica
and local technicians for optimal resolution. For further details see previous
publications44. Contacts were defined as areas where co-localization of both markers
(Iba-1 and TH) occurs between two cells in at least two 0.5-mm-thick optical sections.
A thin area of co-localization can be observed between the two fluorophores. Final
confocal images can be illustrated as they appear throughout the stack of sections as a
simple 0.5-mm layer or as a transparency of all layers merged together. For ubiquitous
staining, such as phalloidin or Cdc42, which label all cells, we normally display single
optical sections (0.5 mm) to appreciate the cellular details of the tissue. In contrast,
when the stack of images (20 mm) was merged in a transparency, the structure of the
tissue was difficult, if not impossible, to observe. In those cases, to avoid saturated
images and appreciate the details and clusters we substantially reduce the intensity of
the scanning laser to avoid over-saturation of the signal. We also show higher
magnifications of the separate channels with better detail to demonstrate that the
identification of clusters and other details is not due to cross reaction or invasion of
the fluorescence from other channels. It is also important tomention that all scanning
were made in sequential mode to avoid cross-reactions.
Three-dimensional reconstructions of the stacks of confocal images were rendered
in Imaris software (Bitplane Scientific Software. Zurich. Switzerland). Different sur-
face effects were applied in the 3D rendering to show the structures in the real planes.
Videos of the rotations and clipping planes were also generatedwith Imaris and edited
in iMovie Software (Apple Inc. Cupertino. CA) for final versions.
Quantification of activated microglia phenotype. Sections of the SNpc were stained
with immunofluorescence to observemicroglial cells (Iba-11 cells). The sections were
scannedwith confocal microscope as described above and terminalmicroglial tips per
microglial cell were quantified along the z-axes. The microglial area and terminal tips
were quantified using confocal images of Iba-1. Scanned confocal planes of 0.5 mm
containing Iba-1 labeled cells were processed with image software Image-J to obtain a
black and white image. The area of 50microglial cells (occupied by Iba-1) of the SNpc
per each animal was measured in these processed images. Similarly, sections were
stained for Iba-1 combined with GM130 and the area occupied by GM130 was
quantified in Iba-11 cells using the samemethod as described for Iba-1. Two different
researchers blindly performed all quantifications.
Quantification of intercellular contacts. Intercellular contacts betweenmicroglial cells
and dopaminergic neurons or fibers were quantified using stereological methods in
confocal stacks of images of the SNpc. The number of contacts Iba-1/TH by field was
quantified in 0.5 mm single layers of the 20 mm-thick confocal stacks of images. The
contacts between microglial cells and dopaminergic neurons were considered when
red and green fluorescence collided in a thin yellow area and were classified in four
categories: Pr-Pr; Contact between microglial process and dopaminergic process, B-
Pr; Contact between amicroglial cell body and dopaminergic process,Pr-B; Processes
of microglial cells in contact with a the cell body of a dopaminergic neuron, B-B;
contact between a microglial cell body and a dopaminergic neuron cell body. The
number of contacts per dopaminergic fiber (Pr-Pr and B-Pr) was quantified con-
sidering the total number of remaining fibers, quantified by unbiased stereological
methods45. The number of B-B and Pr-B contacts per neuron was quantified neuron
by neuron along the z plane. The length of the contacts between the processes and
neurons was also quantified in the Leica Confocal software. All these parameters
(number of contacts, number of dopaminergic fibers and neurons, number of con-
tacts per neuron and the length of the contact) were quantified in 5 dissectors (sample
fields) per each single layer of the 20 mm-thick stacks. Two stacks per brain region per
animal were analyzed. In mice, the final result for the length of the contacts was the
average of at least 50 events recorded per animal.
Detection of MPP1 by HPLC. C57BL6 mice were injected either with saline (n55),
MPTP (n55), HA-1077 (n55) or MPTP1HA-1077 (n55), according to the
protocol described above. Two hours after the treatment, the animals were killed by
cervical dislocation and the striatum was dissected, rapidly frozen in dry ice and
stored at 280uC until analysis. Each sample of the striatum was homogenized in 250
ml of diluent buffer (0.1 M perchloric acid, 2.7 mM EDTA). The MPP1 standards
(Sigma Aldrich) were made with increasing concentrations of MPP1 dissolved in
diluent buffer. The analysis of the presence of MPP1 was performed using a
Shimadzdu HPLC system (UV detector at 285 nm) with a Kromasil 100 C18 reverse
phase column (25 3 0.46 cm, Teknokroma). The mobile phase was 0.1 M sulfuric
acid, 0.075 M TEA, 10% acetonitrile, pH 2.3.
Statistical analysis. The data are expressed as the mean 6 SEM. The statistical
analysis was performed using a one-way ANOVA test following a posthoc analysis.
The null hypothesis was rejected for a a risk equal to 5%.
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